opp-Dibenzoporphyrin Pyridinium Derivatives as Potential G-Quadruplex DNA Ligands

Nuno M M Moura1, José A S Cavaleiro1, Maria Graça P M S Neves1

  • 1LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.

PubMed

Insights

Researchers evaluated tetracationic dibenzoporphyrins as potential anticancer agents. The free-base and zinc(II) complexes showed selectivity for G-quadruplex DNA, a promising target for cancer therapy.

Area of Science:

  • Medicinal Chemistry
  • Biochemistry
  • Molecular Biology

Background:

  • Tumor development is linked to telomerase activity and oncogene expression.
  • Stabilizing G-quadruplex (G4) DNA structures is a promising anticancer strategy.
  • Ligand selectivity for G4 over duplex DNA is crucial for therapeutic efficacy.

Purpose of the Study:

  • To evaluate tetracationic dibenzoporphyrins for G4 DNA stabilization.
  • To assess the selectivity of these ligands towards G4 versus duplex DNA.
  • To explore potential anticancer applications of these G4-binding ligands.

Main Methods:

  • Synthesis and characterization of free-base, Zn(II), and Ni(II) dibenzoporphyrins.
  • Spectroscopic studies (UV-Vis, fluorescence, circular dichroism) to analyze DNA interactions.
  • Evaluation of ligand binding affinity and selectivity for telomeric G4 and calf thymus duplex DNA.

Main Results:

  • Free-base and Zn(II) dibenzoporphyrins exhibited good affinity for DNA structures.
  • Both compounds demonstrated selectivity towards telomeric G4 DNA.
  • Zn(II) and Ni(II) complexes showed aggregation in solution, which was reversed by DNA.

Conclusions:

  • Tetracationic dibenzoporphyrins, particularly the free-base and Zn(II) forms, are effective G4 DNA stabilizers.
  • These ligands show promise as selective G4 binders for cancer therapy.
  • Further investigation into their mechanism and therapeutic potential is warranted.